B
Biomason
Develops sustainable bio-cement building materials using biotechnology to reduce carbon emissions in construction
About Biomason
BioMason is a pioneering startup that operates in the construction industry, specifically in the production of cement. The company is at the forefront of eco-friendly construction, offering a unique solution to the growing demand for cement and concrete. Recognizing the environmental impact of traditional cement production, BioMason has developed a revolutionary product, Biocement®, which is grown naturally, mimicking nature's process. This innovative approach aims to significantly reduce carbon emissions associated with the concrete industry.
Read full description
BioMason's primary clients are likely to be construction companies, architects, and developers who are seeking to reduce their carbon footprint and contribute to a more sustainable future. The company operates in the global construction market, which is under increasing pressure to adopt more environmentally friendly practices.
BioMason's business model is centered around the production and sale of its Biocement®. The company generates revenue by selling this eco-friendly alternative to traditional cement to construction companies and other relevant clients. By offering a product that not only meets the growing demand for cement but also addresses the urgent need for more sustainable construction practices, BioMason is well-positioned to capture a significant share of the market.
In terms of financial prospects, the company's focus on sustainability and its innovative approach to cement production could make it an attractive investment opportunity. As more businesses and governments prioritize reducing carbon emissions, demand for products like Biocement® is likely to increase.
At a glance
- Status
- Operational
- Founded
- 2012
- Headquarters
- Durham, United States
- Employees
- 59
- Open positions
- 4
- Dealroom signal
- 67.1/100
- Industry
- Real Estate
- Sub-industry
- Construction
- Sector
- Real Estate, Biotechnology, Synthetic Biology, Sustainable Development Goals, Urban Tech, Carbon Capture and Storage, Industrial Technology, Advanced Materials, Sustainable Cement, Climate Tech
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES COther financing | Feb 2022 | $65M | $260M | Novo Holdings · Celesta Capital · Martin Marietta · 2150 | ↗ |
| SUPPORT PROGRAMOther financing | Dec 2021 | $0 | — | DARPA | ↗ |
Growth signals
Latest recorded traffic for Biomason is 4.3K monthly website visits, up 30.3% over the last three months. Biomason's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
US National Science Foundation
Series A2 investors entered at this stage
Novo Ventures- NVNoel Ventures
Series B and later4 investors entered at this stage
2150
Novo Holdings
Celesta Capital
Martin Marietta
Other known investors1 additional known investor
DARPA
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Biomason on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Biomason’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.